Prevalence of Chronic Hematopoiesis of Indeterminate Potential Among WTC Responders


Project Number
1 U01 OH012071-01
Institution
State University of New York at Stony Brook
Fiscal Year Awarded
2020
Project Duration
1 year

Description

World Trade Center (WTC) responders experienced an increased risk of leukemia and cardiovascular disease. We plan to study the prevalence of clonal hematopoiesis of indeterminate potential (CHIP), an asymptomatic condition entailing an increased risk of leukemia and cardiovascular disease, among 350 healthy WTC responders and a group of controls. These results will lead to strategies to prevent leukemia and cardiovascular disease in WTC responders.

Contributors

Co-PI: John Mascarenhas (Icahn School of Medicine at Mount Sinai)

Publications

No publications available at this time.

Image of Paolo  Boffetta, MD
Principal Investigator: Paolo Boffetta, MD
State University of New York at Stony Brook
Paolo.Boffetta@stonybrookmedicine.edu
212-659-1474